Checklists by Age
Longevity Checklist for Your 30s
US guidance on screening in your 30s depends on age and risk. Smoking and weight studies report different findings about disease and lifespan.

Your 30s may not feel like the obvious decade for a longevity checklist. Still, several US screening recommendations already apply, and Humanic Blue’s guide starts with measurements that can guide later care.
US guidance in this decade concerns blood pressure, cholesterol and selected screening tests. The 2026 American College of Cardiology/American Heart Association (ACC/AHA) guideline uses PREVENT, a tool for estimating future cardiovascular risk, from age 30 and recommends measuring lipoprotein(a), or Lp(a), at least once in adulthood. Lp(a) is a cholesterol-carrying particle linked to cardiovascular risk. The American Diabetes Association (ADA) says diabetes testing should begin by 35 for people not tested earlier because of risk. The US Preventive Services Task Force (USPSTF) also recommends infection, cervical and mental-health screening for defined groups. These recommendations address disease risk; they do not establish how many extra years screening adds. For living longer, the smoking study below provides a different kind of evidence: an estimated lifespan difference between people who quit and those who continued.
Key Takeaways
- In a large US observational cohort, adults who quit smoking at ages 25 to 34 lived about 10 years longer than those who continued. Supported (direct life-expectancy estimate from an observational cohort, not a randomized trial).
- The 2026 ACC/AHA guideline on blood cholesterol and other blood fats uses PREVENT risk estimation from age 30 and recommends Lp(a) measurement at least once; the ADA recommends diabetes testing by age 35 for people not tested earlier because of risk. Established (guideline recommendations).
- Gaining weight from early to middle adulthood is associated with higher risk of major chronic diseases and lower odds of healthy aging. Supported (observational).
The checklist at a glance
| Item | Guidance or study finding relevant to the 30s | Source |
|---|---|---|
| Blood pressure | Every 3–5 years if normal and low risk; yearly if at increased risk | USPSTF |
| Cholesterol and heart-risk estimate | Blood cholesterol measurement and PREVENT risk estimation used from age 30 | 2026 ACC/AHA guideline |
| Lp(a) | At least once in adulthood | 2026 ACC/AHA guideline |
| Diabetes | Test by 35 under ADA guidance; USPSTF recommends screening ages 35–70 with overweight or obesity | ADA 2026; USPSTF |
| HIV and hepatitis C | Screen at least once; repeat when risk persists | USPSTF |
| Cervical screening | Average-risk people with a cervix ages 30–65: cell testing every 3 years or high-risk human papillomavirus (HPV) testing, alone or with cell testing, every 5 years | USPSTF |
| Depression and anxiety | Depression screening for adults with follow-up systems; anxiety screening through 64; intervals not established | USPSTF |
| Vaccines | Tetanus-diphtheria booster (Td, or Tdap when pertussis is included) every 10 years; annual flu; others by the current schedule | CDC adult schedule |
| Smoking | Quitting before 40 associated with avoiding about 90% of the extra death risk of continued smoking | Jha et al., NEJM |
| Weight | Weight gain associated with higher chronic-disease risk; the study does not establish a personal weight target | Zheng et al., JAMA |
| Activity | 150 minutes of moderate activity plus 2 days of strength work each week | CDC |
| Family history | Record close relatives’ major diagnoses and ages | CDC |

Which numbers are useful to know in your 30s?
Blood pressure. The USPSTF says adults ages 18 to 39 with a prior normal reading and no increased hypertension risk may be screened every three to five years. It suggests annual screening for adults at increased risk, including people with high-normal blood pressure or overweight or obesity, and Black adults.
Cholesterol and heart risk. A lipid panel is a blood test measuring cholesterol and other blood fats. The 2026 ACC/AHA guideline on blood cholesterol and other blood fats uses PREVENT equations to estimate 10- and 30-year cardiovascular risk in adults ages 30 to 79 who have not developed cardiovascular disease. Risk estimates inform a clinician-patient discussion; they do not automatically mean medication is appropriate.
In other words, the guideline treats your 30s as part of the cardiovascular story, not a waiting room before it.
Lp(a), once. The same guideline recommends measuring Lp(a) at least once to identify people at higher cardiovascular risk. The details are in What Is Lipoprotein(a), or Lp(a), and Why Should You Test It?
Blood sugar. The American Diabetes Association’s 2026 Standards of Care say testing should begin by age 35 for people who have not already qualified for earlier risk-based testing; if results are normal, repeating at least every three years is reasonable. The USPSTF recommends screening asymptomatic adults ages 35 to 70 who have overweight or obesity and notes that a three-year interval may be reasonable after a normal result. Which blood tests matter and why is covered in What Blood Tests Should I Get for Longevity?
How does a long-term cardiovascular-risk estimate differ from a short-term one in this decade?
Screenings that apply in your 30s
HIV and hepatitis C. The USPSTF recommends HIV screening for adolescents and adults ages 15 to 65 and hepatitis C screening for adults ages 18 to 79. One-time screening is generally sufficient for people without ongoing risk; repeat testing is appropriate when relevant risks continue.
Cervical screening. Under the current final USPSTF recommendation, people with a cervix ages 30 to 65 may choose cervical cytology (checking cells for changes) every three years, high-risk human papillomavirus (HPV) testing every five years, or both tests together, called cotesting, every five years. The full schedule is in What Health Screenings Do You Need in Your 40s?
Depression and anxiety. The USPSTF recommends depression screening for adults, including pregnant and postpartum people, when systems exist to diagnose, treat and follow up after a positive result. It recommends anxiety screening for adults age 64 or younger, also including pregnant and postpartum people. The USPSTF found insufficient evidence to specify an optimal interval for either screen.
Which habit has a direct life-years estimate?
Most items on this list protect against disease. One has direct evidence on years of life.
In a 2013 prospective cohort study, Prabhat Jha of the Centre for Global Health Research in Toronto and colleagues linked survey data from about 200,000 US adults to death records. Compared with never-smokers, current smokers had about three times the mortality rate and more than 10 years shorter life expectancy. People who quit at ages 25 to 34 lived about 10 years longer than those who continued, while those who quit at ages 35 to 44 lived about nine years longer. The investigators estimated that quitting before age 40 avoided about 90% of the excess mortality risk associated with continued smoking. This refers to the extra risk above that of never-smokers, not a 90% reduction in every cause of death.
This is the only item on this checklist backed here by a direct estimate of years of life. It remains observational evidence: people who quit may differ from people who continue in ways the analysis cannot fully capture.

Build: habits that compound
Weight trends. Researchers at the Harvard T.H. Chan School of Public Health studied about 118,000 adults and compared recalled early-adult weight with weight at age 55. Greater weight gain was associated with higher incidence of type 2 diabetes, cardiovascular disease, obesity-related cancer and mortality, and lower odds of healthy aging. The study was observational, depended partly on recalled weight and involved predominantly White health professionals, so it cannot show that weight gain alone caused the outcomes or represent every population equally well.
Activity and strength. The CDC recommends at least 150 minutes of moderate-intensity aerobic activity, such as brisk walking, each week and muscle-strengthening activity on at least two days. For the evidence behind maintaining muscle and function, see Why Muscle Matters for Longevity.
Eating patterns. In two large US health-professional cohorts, closer adherence to four overlapping dietary patterns was associated with lower mortality over as long as 36 years; the design cannot establish that the eating patterns caused the difference (Shan et al., 2023). That evidence is unpacked in What Should I Eat to Live Longer?
Vaccines. The current CDC adult schedule includes annual influenza vaccination and a tetanus-diphtheria (Td) or tetanus-diphtheria-pertussis (Tdap) booster every 10 years after the initial adult Tdap dose, with other vaccines depending on age, prior doses, pregnancy, health conditions and exposure risk. Because schedules change, ask a clinician or pharmacist which doses you are due for.
Why record your family history?
Family history can change which screening tests are appropriate and when they begin. The CDC advises recording major diagnoses and the age they began in close blood relatives, then sharing that record with a healthcare professional. Early heart disease, diabetes and certain cancers in close relatives are among the histories that can change risk assessment or prompt earlier screening.
Which screening assumptions change when guidance accounts for family history?
What’s Interesting
The 2026 dyslipidemia guideline starts PREVENT risk estimation at 30 and recommends Lp(a) measurement at least once. The smoking cohort provides a different kind of result: an estimated difference of roughly 10 years of life between people who quit at ages 25 to 34 and those who continued. One is guideline-directed risk assessment; the other is an observational lifespan estimate. They should not be treated as interchangeable evidence.
What This Means in Practice
The USPSTF screening recommendations depend on age, risk and past results. The ADA and ACC/AHA recommendations address different tests and risks; they do not form one compulsory testing package. A question for primary care is which recommendation applies and how an abnormal result would change care.
For people seeking smoking-cessation support, the CDC lists 1-800-QUIT-NOW, which transfers callers to their state quitline. A pharmacist can explain vaccine eligibility, and a registered dietitian can discuss eating patterns and weight concerns.
Bottom Line
For living longer and better in the 30s, US guidance addresses blood pressure, cholesterol-based risk assessment, Lp(a), diabetes, infection and cervical screening, mental health and vaccines. The eligibility and timing belong to each named recommendation; this article does not establish a personal screening schedule. For people who smoke, quitting is the action on this list with a direct estimated life-years difference. Weight trends, regular activity and a written family history round it out. How much any single item changes an individual’s lifespan is unknown, which is a good reason to review the whole list with a primary care clinician.
A NOTE FROM LONGEVITY365
We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.
We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.
Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.
Reader Questions
A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.
- 01Which part of this guide feels easiest to turn into a better question for a routine visit?
- 02Where do you still feel the line is blurry between a useful check and more testing than you need?
- 03What would make the next conversation clearer: timing, eligibility, possible harms, or what happens after an abnormal result?
Extra Insights & Sources
The evidence summaries and linked sources behind this article.
What We Know
- A large US observational cohort estimated that quitting smoking before 40 avoided about 90% of the excess mortality risk associated with continuing. Supported.
- Blood pressure, cholesterol-based risk estimation, Lp(a), diabetes, HIV, hepatitis C, cervical, depression and anxiety screening all have US guideline support that applies in the 30s. Established.
- Adult weight gain is associated with more chronic disease and less healthy aging. Supported.
What We Don’t Know
- Whether starting statins (medicines that lower cholesterol) or other lipid-lowering treatment in otherwise low-risk adults in their 30s improves long-term clinical outcomes. The guideline uses calculated risk plus individual risk factors to guide decisions. Uncertain.
- How much any single habit adds to lifespan for an individual. Population estimates aren’t personal forecasts. Unknown.
Sources
- USPSTF, Hypertension in Adults: Screening (2021). Current final preventive-services recommendation used for the suggested intervals: every three to five years may be appropriate for adults ages 18–39 with a prior normal reading and no increased risk; annual screening is suggested for adults at increased risk. The USPSTF notes that evidence on the optimal interval is limited. Recommendation
- American Heart Association/American College of Cardiology, 2026 Guideline on the Management of Dyslipidemia. Official guideline summary supporting PREVENT 10- and 30-year risk assessment in primary prevention for adults ages 30–79 and Lp(a) measurement at least once. This is a guideline recommendation, not evidence that screening or medication adds a known number of years to an individual life. Top Things to Know
- American Diabetes Association, Standards of Care in Diabetes—2026, Section 2. Current professional standard supporting testing by age 35 for people not already tested because of overweight or obesity plus risk factors, and repeating at least every three years after normal results. This is clinical guidance; screening frequency may change with symptoms and risk. Full guideline section
- USPSTF, Prediabetes and Type 2 Diabetes: Screening (2021). Current final recommendation supporting screening asymptomatic, nonpregnant adults ages 35–70 who have overweight or obesity; it describes three-year rescreening after a normal result as reasonable while noting the optimal interval is uncertain. Recommendation
- USPSTF, HIV Infection: Screening (2019), and Hepatitis C Virus Infection: Screening (2020). Current final recommendations supporting HIV screening from ages 15–65 and HCV screening from ages 18–79. One-time screening is generally adequate without ongoing risk; repeat screening is reasonable when risks continue. HIV recommendation; HCV recommendation
- USPSTF, Cervical Cancer: Screening (2018). Current final recommendation used for the three options from ages 30–65: cytology every three years, primary high-risk HPV testing every five years, or cotesting every five years. Screening can differ for people at increased risk or with relevant prior findings. Recommendation
- USPSTF, Depression and Suicide Risk in Adults and Anxiety Disorders in Adults (2023). Current recommendations supporting adult depression screening when diagnosis, treatment and follow-up systems are available, and anxiety screening through age 64. The USPSTF found insufficient evidence to set an optimal interval; it also found insufficient evidence for anxiety screening at age 65 or older. Depression recommendation; anxiety recommendation
- Jha P, et al., New England Journal of Medicine (2013), PMID 23343063. Prospective US cohort linking National Health Interview Survey data from 113,752 women and 88,496 men to death records. Supported the approximately threefold mortality rate in current smokers, more than 10 years shorter life expectancy, about 10 years gained by quitting at ages 25–34, about nine years at 35–44, and roughly 90% avoidance of excess mortality risk when quitting before 40. Because the study observed people rather than assigning them to quit or continue, other differences between the groups may still affect the result. PubMed record
- Zheng Y, et al., JAMA (2017), PMID 28719691. Prospective analysis of 92,837 women and 25,303 men comparing recalled early-adult weight with weight at age 55 and subsequent chronic disease, mortality and healthy-aging outcomes. Supports associations, not causation; recalled weight and a predominantly White health-professional population limit generalizability. PubMed record
- Shan Z, et al., JAMA Internal Medicine (2023), PMID 36622660. Prospective cohort analysis of 75,230 women and 44,085 men followed for up to 36 years. Supports the association between greater adherence to four dietary patterns and lower mortality. Food-frequency questionnaires and observational design prevent causal conclusions. PubMed record
- CDC, Physical Activity Guidelines for Adults (reviewed 2025). Current public-health guidance supporting at least 150 minutes of moderate-intensity aerobic activity weekly and muscle-strengthening activity on at least two days. It is a population target, not an individualized exercise prescription. Guidance
- CDC, Adult Immunization Schedule by Age (current compliant schedule accessed September 29, 2026). Supports annual influenza vaccination, adult Tdap followed by Td or Tdap every 10 years, and age- or risk-specific vaccines. Vaccine recommendations and the governing schedule can change, so the live schedule should be checked. Current schedule
- CDC, Family Health History and Adults (reviewed August 24, 2026). Supports recording diagnoses and ages at onset among close blood relatives and sharing the information with a clinician because family history can change risk assessment, screening choice and timing. CDC guidance
- CDC, Quitlines and Other Cessation Support Resources (2025). Supports that 1-800-QUIT-NOW automatically transfers callers to their state quitline and that quitlines are evidence-based cessation services. CDC resource
Photo credits
Images from Pexels.
- featured: Photo by cottonbro studio — original Pexels photo.
- inline-1: Photo by Mizuno K — original Pexels photo.
- inline-2: Photo by Pavel Danilyuk — original Pexels photo.
Leave a Reply